Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you
ODYSSEY Outcomes
NEJM Odyssey Outcomes
The EXPLORER Study
The ROSETTE Study
Odyssey Outcomes - Mortality
The ACTE Study
Odyssey Outcomes - CABG Results
Odyssey Outcomes - PVD Results
PCSK9 inhibitors and ACS
VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients
Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism
Changing trends in VTE: Pulmonary Embolism Cases on Rise within the Last Decade
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
PCSK9 inhibitors and ACS
VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients
Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism
Key Learnings in Dyslipidemia by Prof. Kausik Ray - 2021 EAS Congress
%20from%20the%20SAFEHEART%20registry.jpeg)
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry
Atherosclerotic Cardiovascular Disease Risk Assessment
PCSK9 Inhibitors in Cardiovascular Disease
APSC Consensus Recommendations on Dyslipidemia
Single-Pill Combinations in Dyslipidemia
PCSK9i and Prevention of CVD
.png)
VTE prevention for acutely ill patients
VTE Risk Assessment in Surgical Patients
Events
Stay up to date and register for the latest events and view webinar recordings.
Venous Thromboembolism Burden
Sanofi Thrombosis Summit
24:30
Dyslipidemia Webinars: Optimizing Dyslipidemia management​
Challenges of VTE Prophylaxis in Surgery
Venous Thromboembolism in Acutely Medically Ill Patients
Hypertension - The Most Important Disease in Medicine
Dyslipidemia Webisodes: Mortality data with Prof. Tunon
Hypertension - The Most Important Disease in Medicine II
Dyslipidemia Expert Exchange: Best practice approaches in dyslipidemia management
19:24
VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond
06:13
VTE Safety Zone: The Role of Thromboprophylaxis for the Prevention of VTE
